Exome Asset Management’s Aprea Therapeutics APRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,972
| Closed | -$59.1K | – | 57 |
|
|
2025
Q1 | $59.1K | Sell |
28,972
-98,988
| -77% | -$202K | 0.05% | 49 |
|
|
2024
Q4 | $420K | Sell |
127,960
-9,214
| -7% | -$30.2K | 0.32% | 53 |
|
|
2024
Q3 | $377K | Hold |
137,174
| – | – | 0.26% | 56 |
|
|
2024
Q2 | $558K | Buy |
+137,174
| New | +$558K | 0.5% | 45 |
|